Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FormerXBC Inc XEBEQ

Xebec Adsorption Inc designs, engineers, and manufactures products that are used for purification, separation, dehydration, and filtration equipment for gases and compressed air. The company operates in three reportable segments: Systems, Corporate and other, and Support. Its product lines are natural gas dryers for natural gas refueling stations, compressed gas filtration, biogas purification, associated gas, engineering services, and air dryers. The company's geographical segments are United States, Canada, China, Other, Korea, Italy, and France.


GREY:XEBEQ - Post by User

Post by retiredcfon Mar 30, 2022 10:52am
246 Views
Post# 34558911

Raymond James Upgrade

Raymond James UpgradeToo many posts to determine whether this has already been posted. GLTA

Touting the potential stemming from the release of its three-year strategic plan, Raymond James analyst David Quezada upgraded Xebec Adsorption Inc.  to “outperform” from “market perform.”

“As highlighted at the company’s Investor Day, XBC is targeting a trio of significant energy transition opportunities including RNG, hydrogen, and carbon capture, expected to drive significant growth in coming years with a 40-per-cent projected CAGR [compound annual growth rate] out to 2024 as per the company’s strategic update,” he said. “We also believe management projected confidence with respect to the ramp up of the standardized Biostream RNG upgrading unit —something we consider to be a key driver for the business.”

Mr. Quezada maintained a $3 target, a penny above the consensus, for the Quebec-based company’s shares.

“In recent months, we have noted our concerns on cost inflation and supply chain challenges as Xebec looks to significantly increase Biostream manufacturing volumes and roll out its hydrogen hub strategy,” he said. “That said, we felt management projected confidence on these respective initiatives and believe the company’s new CEO and other key members of senior management are experienced operators able to execute on this strategy. In light of this, as well as the magnitude of the above noted opportunities, which we do not believe are reflected in XBC’s valuation.”

 

<< Previous
Bullboard Posts
Next >>